233 related articles for article (PubMed ID: 12135299)
1. Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction.
Lofthouse RA; Boitano MA; Davis JR; Jinnah RH
J South Orthop Assoc; 2000; 9(3):175-81. PubMed ID: 12135299
[TBL] [Abstract][Full Text] [Related]
2. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
[TBL] [Abstract][Full Text] [Related]
3. Preoperative epoetin alfa vs autologous blood donation in primary total knee arthroplasty.
Deutsch A; Spaulding J; Marcus RE
J Arthroplasty; 2006 Aug; 21(5):628-35. PubMed ID: 16877146
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of perioperative epoetin alfa in patients scheduled for elective hip surgery.
Laupacis A
Semin Hematol; 1996 Apr; 33(2 Suppl 2):51-3; discussion 54. PubMed ID: 8723583
[TBL] [Abstract][Full Text] [Related]
5. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty.
Gonzalez-Porras JR; Colado E; Conde MP; Lopez T; Nieto MJ; Corral M
Transfus Med; 2009 Feb; 19(1):35-42. PubMed ID: 19302453
[TBL] [Abstract][Full Text] [Related]
6. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery.
Goldberg MA; McCutchen JW; Jove M; Di Cesare P; Friedman RJ; Poss R; Guilfoyle M; Frei D; Young D
Am J Orthop (Belle Mead NJ); 1996 Aug; 25(8):544-52. PubMed ID: 8871752
[TBL] [Abstract][Full Text] [Related]
7. Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study.
Christodoulakis M; Tsiftsis DD;
Ann Surg Oncol; 2005 Sep; 12(9):718-25. PubMed ID: 16052276
[TBL] [Abstract][Full Text] [Related]
8. Epoetin alfa plus autologous blood donation and normovolemic hemodilution in patients scheduled for orthopedic or vascular surgery.
Tryba M
Semin Hematol; 1996 Apr; 33(2 Suppl 2):34-6; discussion 37-8. PubMed ID: 8723580
[TBL] [Abstract][Full Text] [Related]
9. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.
Chun TY; Martin S; Lepor H
Urology; 1997 Nov; 50(5):727-32. PubMed ID: 9372883
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
Stovall TG
J Reprod Med; 2001 May; 46(5 Suppl):531-8. PubMed ID: 11396387
[TBL] [Abstract][Full Text] [Related]
11. Perisurgical use of epoetin alfa in orthopedic surgery patients.
Adamson J
Semin Hematol; 1996 Apr; 33(2 Suppl 2):55-8; discussion 59. PubMed ID: 8723584
[TBL] [Abstract][Full Text] [Related]
12. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients.
de Andrade JR; Jove M; Landon G; Frei D; Guilfoyle M; Young DC
Am J Orthop (Belle Mead NJ); 1996 Aug; 25(8):533-42. PubMed ID: 8871751
[TBL] [Abstract][Full Text] [Related]
13. Patients with and without rheumatoid arthritis benefit equally from preoperative epoetin-alpha treatment.
Slappendel R; Weber EW; Hémon YJ; Mähler S; Dalén T; Rouwet EF; van Os JJ; Vosmaer A; van der Ark PD
Acta Orthop; 2006 Aug; 77(4):677-83. PubMed ID: 16929448
[TBL] [Abstract][Full Text] [Related]
14. Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.
Quirt I; Kovacs M; Couture F; Turner AR; Noble M; Burkes R; Dolan S; Plante RK; Lau CY; Chang J
Oncologist; 2006 Jan; 11(1):73-82. PubMed ID: 16401716
[TBL] [Abstract][Full Text] [Related]
15. Autologous blood donation plus epoetin alfa in nonanemic orthopedic surgery patients.
Baudoux E
Semin Hematol; 1996 Apr; 33(2 Suppl 2):31-2; discussion 33. PubMed ID: 8723579
[TBL] [Abstract][Full Text] [Related]
16. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
Scott SN; Boeve TJ; McCulloch TM; Fitzpatrick KA; Karnell LH
Laryngoscope; 2002 Jul; 112(7 Pt 1):1221-9. PubMed ID: 12169903
[TBL] [Abstract][Full Text] [Related]
17. Enhanced efficacy of autologous blood donation with epoetin alfa.
Nydegger U
Semin Hematol; 1996 Apr; 33(2 Suppl 2):39-40; discussion 41-2. PubMed ID: 8723581
[TBL] [Abstract][Full Text] [Related]
18. Epoetin alfa. A bloodless approach for the treatment of perioperative anemia.
Faris PM; Ritter MA
Clin Orthop Relat Res; 1998 Dec; (357):60-7. PubMed ID: 9917701
[TBL] [Abstract][Full Text] [Related]
19. Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy.
Granetto C; Ricci S; Martoni A; Pezzella G; Testore F; Mattioli R; Lampignano M; Tacconi F; Porrozzi S; Gasparini G; Mantovani G;
Oncol Rep; 2003; 10(5):1289-96. PubMed ID: 12883695
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
